Peter Gelinas

Executive Officer at CoRegen.

Earliest Form D on file: Feb 2026

Filed Feb 26, 2026

CoRegen

Cancer therapy that reprograms regulatory T cells

Biotech, Aspen CO

Named, Executive Officer.

$13.5M

sold of $13.5M offered

Network

At CoRegen

13 people

Sonja Nelson
Together on 1 filing
Executive Officer, signed as Chief Financial Officer
Steve Gorlin
Together on 1 filing
Executive Officer, Director
Bert W. O'Malley
Together on 1 filing
Director
Edward J. Benz, Jr.
Together on 1 filing
Director
Jonathan Simons
Together on 1 filing
Director
Lee Fleisher
Together on 1 filing
Director

7 more at CoRegen